DOCSLIB.ORG

180 Investors Longevity in UK 180 Investors / Longevity in UK

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
180 Investors Longevity in UK 180 Investors / Longevity in UK 180 Investors Longevity in UK 180 Investors / Longevity in UK 1. 24 Haymarket 31. Catapult Ventures 61. Franklin Templeton Investments 2. 4BIO Capital 32. Cedar Mundi Ventures 62. Gilde Healthcare 3. Abingworth 33. Celgene 63. GlaxoSmithKline 4. Advent Life Sciences 34. Cera 64. Global Health Investment Fund (GHIF) 5. Advent Venture Partners 35. Charterhouse Capital Partners 65. Goldman Sachs 6. Agent Capital 36. China Medical System Holdings 66. Grima Ventures 7. Aisling Capital Limited 67. Guinness Asset Management 8. Albion Capital Group 37. Clarendon Fund Managers 68. Hambro Perks Ltd. 9. Amadeus Capital Partners 38. Clarus Ventures 69. HAX 10. Angel CoFund 39. Clough Capital Partners 70. Henderson Global Investors 11. Angel Investment Network 40. Clydesdale Bank 71. Horizon Discovery 12. Angels in MedCity 41. Cowen Group 72. Hoxton Ventures 13. Aquarius Equity Partners 42. Creandum 73. Human Longevity 14. ARCH Venture Partners 43. Credo Ventures 74. Hygea VCT 15. Archangels 44. Crowdcube 75. Imperial Innovations 16. Arix Bioscience 45. Deerfield 76. Index Ventures 17. Baillie Gifford 46. Downing LLP 77. Innovate U.K. 18. Balderton Capital 47. Downing Ventures 78. Innovations New Ventures 19. Bank of America Merrill Lynch 48. Draper Esprit 79. Invesco 20. Baxter International 49. Draper Fisher Jurvetson (DFJ) 80. Invesco Perpetual 21. Beringea 50. EcoR1 Capital 81. Invest Northern Ireland 22. Bethnal Green Ventures 51. Edmond de Rothschild Investment 82. J.P. Morgan Securities Inc. 23. Bill & Melinda Gates Foundation Partners 83. JamJar Investments 24. BioMotiv 52. Enterprise Ventures 84. Janssen Pharmaceuticals ​ 25. BioScience Managers Limited 53. Equity Gap 85. Juno Capital 26. Calculus Capital 54. European Commission, European 86. Kairos 27. California Institute for Regenerative Innovation 87. Kima Ventures Medicine 55. Eurostars 88. Kinnevik AB 28. Cambridge Angels Group 56. F-Prime Capital Partners 89. KIZOO 29. Cambridge Capital Group 57. Finance Wales 90. Korea Investment Partners 30. Cambridge Innovation Capital plc 58. Forbion Capital Partners 59. Foresite Capital 60. Fountain Healthcare Partners 333 180 Investors / Longevity in UK 91. KTB Network 121. OrbiMed 151. Teva Pharmaceutical Industries 92. L Marks 122. Oxford Capital Partners 152. The Capital Fund 93. Lansdowne Partners 123. Oxford Technology Management 153. The Discovery Fund, Cambridge 94. Lanstead Capital 124. Parkwalk Advisors Ltd University 95. Lundbeck 125. Pavilion Capital 154. The North West Fund 96. Lundbeckfonden Ventures 126. Pitch@Palace 155. Third Rock Ventures 97. Masa Life Science Fund 127. Quester Capital 156. Touchstone Innovations 98. MassChallenge 128. QVentures 157. Twist Bioscience 99. Mentor Capital 129. QVT Financial 158. UCL Technology Fund 100. Mercia Technologies 130. RA Capital Management 159. UCLB 101. Merlin Nexus 131. Redmile Group 160. UK Innovation & Science Seed Fund 102. Ministry of Defence - UK 132. Ridgeback Capital Rainbow Seed Fund 103. Morgan Stanley 133. Roche Venture Fund 161. UK Trade & Investment (UKTI) 104. MVM Life Science Partners 134. Rock Springs Capital 162. University of Bristol Enterprise Fund 105. Nesta Ventures 135. RTW Investments LLC 163. University of Cambridge Enterprise 106. New Enterprise Associates 136. Scottish Enterprise 164. University of Edinburgh 107. New Leaf Venture Partners 137. Seedcamp 165. University of Oxford 108. New Wave Ventures 138. Seneca Partners 166. UnLtd 109. Newable Private Investing 139. Sixth Element Capital 167. Upsher Smith Laboratories 110. Nextech Invest 140. Smith & Nephew 168. venBio Partners 111. NHN Investment 141. SOSV 169. Venrock 112. NHS England 142. SPARK Impact 170. Versant Ventures 113. North West Fund for Biomedical 143. SR One 171. Vertex Pharmaceuticals 114. Novartis Venture Fund 144. Stanley Family Foundation 172. Vivo Capital 115. Novo A/S 145. Sustainable Development Technology 173. Wellcome Trust 116. NVM Private Equity Canada 174. Wellington Capital Management 117. NYU Innovation Venture Fund 146. Syncona Partners LLP 175. White Rose Technology Seedcorn 118. Oceania Capital Partners 147. Takeda Ventures Fund 119. Octopus Ventures 148. Technology Venture Partners 176. Winton Ventures 120. Odey Asset Management 149. techstart NI 177. Woodford Investment Management 150. Temasek Holdings 178. Wren Capital 179. Xenos 180. yabeo capital 334 24 Haymarket 24 Haymarket is a leading Investment network, which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs and senior operators. Investing up to £5 million in growth companies in UK and Europe. 24 Haymarket has invested in more than 50 high-growth businesses. Website: www.24haymarket.com Number of Employees: 1-10 Location: London, United Kingdom Founded in: 2011 Portfolio Companies: Sphere Fluidics 335 4BIO Capital 4BIO Capital Partners is an emerging asset manager focusing on private equity and venture capital in high growth and high return segments of biotech - biologics, gene and cell therapy and bioinformatics. Advanced biotherapeutics are key to addressing the challenges of modern-day healthcare – spiraling cost of long-term chronic illness and lack of cures. Website: www.4biocapital.com Number of Employees: 1-10 Location: London, United Kingdom Founded in: 2014 Portfolio Companies: Orchard Therapeutics 336 Abingworth Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs to develop their ideas into products that have a dramatic impact on health. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies, and across all life sciences sectors. Supporting its portfolio companies with a team of 27 at offices in London, Menlo Park, and Boston, Abingworth has invested in 142 life science companies, completed 60 IPOs and 40 mergers and acquisitions. Website: www.abingworth.com Number of Employees: 11-50 Location: London, United Kingdom Founded in: 1973 Portfolio Companies: CRISPR Therapeutics 337 Advent Life Sciences Advent Life Sciences is one of Europe's leading venture teams investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences, principally in new drug discovery, enabling technologies, and med tech. Realisations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe, Website: www.adventls.com Number of Employees: 11-50 Location: London, United Kingdom Founded in: 2010 Portfolio Companies: Levicept 338 Advent Venture Partners Advent Venture Partners is one of Europe's most successful growth and venture capital investors in market-leading tech and life sciences businesses. Website: http://adventventures.com Number of Employees: 11-50 Location: London, United Kingdom Founded in: 1981 Portfolio Companies: NeRRe Therapeutics 339 Agent Capital Agent Capital is a biotech venture capital firm focused on investing in novel therapeutics that address unmet patient need.Balanced two-pronged approach, between clinical stage companies with high commercial potential and early-stage transformative technologies prime for future M&A. From preclinical to commercial stage, Agent Capital makes direct equity investments across all stages of development. Agent Capital's team partners with scientists, entrepreneurs and other investors to develop the next generation of healthcare innovations, focusing on making a difference in patients’ lives. Website: www.agentcapital.com Number of Employees: n/a Location: Cambridge, United States Founded in: n/a Portfolio Companies: Orchard Therapeutics 340 Aisling Capital Aisling Capital believes the next decade will be marked by a revolution in healthcare driven by new therapeutics generated by biotechnology. The completion of the human genome has given scientists new insights into the causes of human disease. These insights, combined with the past 20 years of developments in the biotechnology industry, are leading to rapid expansion of novel approaches toward the diagnosis, prevention, and treatment of life-threatening illnesses. These advances have led to an ever-increasing demand for capital to complete the development and commercialization of new therapeutics. Aisling Capital ‘s goal is to support the leading global healthcare companies that are building on these technical and medical breakthroughs to commercialize new healthcare products. Website: www.aislingcapital.com Number of Employees: 11-50 Location: New York, United States Founded in: 2000 Portfolio Companies: Verona Pharma 341 Albion Capital Group Albion typically invests £2-5m for a minority stake Series A and early Series B. Albion Capital Group supports outstanding entrepreneurs who have demonstrated product-market fit, a clear go to market strategy and long term differentiation in a growth market. Albion Capital Group looks at most sectors, with a particular focus on digital B2B companies – enterprise software and technology services – across a broad range of sectors, including digital health, cybersecurity, martech and fintech. Companies that benefit from macro themes around disruption, digital transformation, and the trend towards a data-driven economy are particularly attractive. Albion Capital Group
Load more

Recommended publications
  • Draper Fisher Jurvetson
    TEAM PORTFOLIO NEWS ABOUT DFJ DFJ NETWORK HOME BACK DRAPER FISHER JURVETSON, DFJ FRONTIER, AND ZONE VENTURES AWARD $250,000 TO NEUROVIGIL IN FOURTH ANNUAL DFJ VENTURE CHALLENGE Draper Fisher Jurvetson, DFJ Frontier, and Zone Ventures Award $250,000 to NeuroVigil in Fourth Annual DFJ Venture Challenge By: Press Release May. 28, 2008 UC San Diego Startup Bests 16 Teams from 12 Universities in Competition for Seed Funding MENLO PARK, Calif ‐‐ Leading early‐stage venture capital firms Draper Fisher Jurvetson (DFJ) and its network partners DFJ Frontier and Zone Ventures hosted the fourth annual DFJ Venture Challenge in Menlo Park on Wednesday. With a grand prize of $250,000 in seed stage funding, the competition is believed to be the largest winner‐take‐all business plan competition for university students. During the morning session, 16 teams from 12 universities on the West Coast presented business plans to a panel of 10 judges, comprised of venture capitalists from the DFJ Network. Six teams were selected as finalists and presented extended versions of their business plans and answered further questions from the judges in a second round of competition in the afternoon. Following the final round of judging, NeuroVigil was awarded $250,000 in seed funding. NeuroVigil is poised to revolutionize brain analysis and plans to target the sleep, transportation, and pharmaceutical industries. The company, which comprises several Nobel Laureates and leading business strategists, was founded in 2007 by Dr. Philip Low, who, as a graduate student at the Salk Institute, developed a new way to analyze brain activity using a single non‐invasive probe.
    [Show full text]
  • Diversity in UK Venture Capital 2019 2
    A report by Diversity VC Sponsored by Silicon Valley Bank Published July 2019 Diversity in UK Venture Capital 2019 2 With thanks to our Research Team Executive Team Diversity Research Team 2019 Diversity VC Team Travis Winstanley Diane Albouy David Kelnar Shriya Anand Research Lead, Co-founder, Diversity VC Balderton Capital MMC Ventures Bain & Company Catalis Group Meriwether Beckwith Dan Mackie Seb Butt Lillian Li Oxford Capital Craft.co Co-founder, Diversity VC Kirsty MacDonald Eight Roads Ventures Victoria Bernath JamJar Investments Juliet Bailin University of York Mosaic Ventures Francesca Warner, CEO Patricia Nicola Co-founder, Diversity VC James Downing Seedrs Ben Goldsmith Diversity VC Silicon Valley Bank Goldsmith Communications Shane Porter Bain & Company Sarah Millar Blake Falk Citylight Capital Bain & Company Magda Posluszny Speed Invest Esther Delignant Rodriguez Christina Franzeskides Oxford Capital Entrepreneur First (LD12) Lucy Rands ETF Partners Tong Gu Michael Tefula Downing Ventures Accelerated Digital Ventures Abhi Setia London School of Economics Belinda Gurung Farooq Abbasi Constanoa Ventures JamJar Investments Shrenik Sanghrajka Bain & Company Harry Hamer London Venture Partners Imran Tehal DN Capital Julie Kainz Salesforce Ventures Ella Wales Bonner JamJar Investments Full list of contributors is available in the Appendix. Diversity in UK Venture Capital 2019 3 Contents Foreword 5 Introduction 6 Key Findings 10 Gender 12 Education 17 Career 21 Ethnicity 24 Discussion 26 Conclusion 36 About Diversity VC 40 Appendix 42 References 42 Our Contributors 42 Our Sponsor 46 Our Partners and Collaborators 47 Our Methodology 48 Firms in our analysis 52 Diversity in UK Venture Capital 2019 4 Launch of Women in UK Venture Capital (2017) Source: Diversity VC Diversity in UK Venture Capital 2019 Introduction Foreword 5 A warm welcome to ‘Diversity in UK Venture Capital 2019’.
    [Show full text]
  • Oral History of William H. Draper III
    Oral History of William H. Draper III Interviewed by: John Hollar Recorded: April 14, 2011 Mountain View, California CHM Reference number: X6084.2011 © 2011 Computer History Museum Oral History of William H. Draper III Hollar: So Bill, here I think is the challenge. There's been a great oral history done of you at Berkeley; and then you've written your book. So there's a lot of great information about you on the record. So what I thought we would try to— Draper: That's scary. I hope I say it the same way. Hollar: Well, your version of it is on the record, that's for sure. So I wanted to cover about eight areas in the hour and a half that we have. Draper: Okay. Hollar: Which is quite a bit. But I guess that's also a way of saying—we can go into as much or as little detail as you want to. But the eight areas that I was most interested in covering are your early life and your education; your early career—and with that I mean Inland Steel and meeting Pitch Johnson, and Draper, Gaither & Anderson, that section. Draper: Good. Hollar: Then Draper & Johnson—you and Pitch really getting into it together; then, of course, Sutter Hill and that very incredible fifteen-year period. Draper: Yeah, that was a good period. Hollar: A little bit of what you call "the lost decade." Draper: Okay. Hollar: Then what I call the Draper Richards Renaissance. Draper: Good. Hollar: And kind of the second chapter of venture capital for you.
    [Show full text]
  • Complete 2020 Annual Report (PDF)
    2020 REPORT TO THE COMMUNITY Youth wade into Crissy Field Marsh during Project WISE in fall 2019 (See story, page 5). Crissy Field Center moves into new space at DEAR FRIEND the Tunnel Tops in 2021. We’ll improve those trails we missed so much. We’ll welcome back OF THE PARKS, our volunteers and visitors with open arms—or maybe a friendly wave. With our partners, our hat a year to start as only the second focus on making parks accessible for all—so W CEO in the history of the Golden Gate that everyone feels welcome in parks and can National Parks Conservancy. Throughout this enjoy the many health benefits of nature—is Report to the Community, we shine a light on more important now than ever. our major accomplishments of 2019. We had That’s why I’m so grateful for my first year no idea what was just around the corner. at the helm of the Parks Conservancy. I’ve I came into this job believing strongly in gotten to see the park spirit shine bright under the power of national parks to inspire and the toughest conditions. The snapshot of heal. The Bay Area shelter-in-place orders 2019 you’ll get in this report shows us what’s somehow strengthened that conviction. When possible for our long-term future, and I can’t we lose something, we miss it more than ever. wait to get there. It may take some time to And, we learn a powerful lesson in not taking recover, but with your help, our parks will it for granted.
    [Show full text]
  • Self-Driving Car Autonomous System Overview
    Self-Driving Car Autonomous System Overview - Industrial Electronics Engineering - Bachelors’ Thesis - Author: Daniel Casado Herráez Thesis Director: Javier Díaz Dorronsoro, PhD Thesis Supervisor: Andoni Medina, MSc San Sebastián - Donostia, June 2020 Self-Driving Car Autonomous System Overview Daniel Casado Herráez "When something is important enough, you do it even if the odds are not in your favor." - Elon Musk - 2 Self-Driving Car Autonomous System Overview Daniel Casado Herráez To my Grandfather, Family, Friends & to my supervisor Javier Díaz 3 Self-Driving Car Autonomous System Overview Daniel Casado Herráez 1. Contents 1.1. Index 1. Contents ..................................................................................................................................................... 4 1.1. Index.................................................................................................................................................. 4 1.2. Figures ............................................................................................................................................... 6 1.1. Tables ................................................................................................................................................ 7 1.2. Algorithms ........................................................................................................................................ 7 2. Abstract .....................................................................................................................................................
    [Show full text]
  • Buyouts' List of Candidates to Come Back to Market In
    32 | BUYOUTS | December 3, 2018 www.buyoutsnews.com COVER STORY Buyouts’ list of candidates to come back to market in 2019 Firm Recent Fund Strategy Vintage Target ($ Amount Raised Year Mln) ($ Mln) Advent International Advent International GPE VII, L.P. Large Buyout 2012 $12,000.00 $13,000.00 Advent International Advent Latin American Private Equity Fund VI, L.P. Mid Buyout 2015 $2,100.00 $2,100.00 American Industrial Partners American Industrial Partners Capital Fund VI LP US MM Buyout 2015 N/A $1,800.00 Apollo Global Management Apollo Investment Fund IX Mega Buyout 2017 $23,500.00 $24,700.00 Aquiline Capital Partners Aquiline Financial Services Fund III Mid Buyout 2015 $1,000.00 $1,100.00 Arlington Capital Partners Arlington Capital Partners IV LP Mid Buyout 2016 $575.00 $700.00 Black Diamond Capital Management BDCM Opportunity Fund IV Turnarounds 2015 $1,500.00 $1,500.00 Blackstone Group Blackstone Real Estate Partners VIII LP Global Real Estate Opp 2015 $4,518.11 $4,518.11 Bunker Hill Capital Bunker Hill Capital II Lower mid market buyout 2011 $250.00 $200.00 CCMP Capital CCMP Capital Investors III, L.P. Buyout/Growth Equity 2014 N/A $1,695.65 Centerbridge Partners Centerbridge Capital Partners III Global Dist Debt Control 2014 $5,750.00 N/A Centerbridge Partners Centerbridge Special Credit Partners III Hedge Fund 2016 $1,500.00 N/A Charlesbank Capital Partners Charlesbank Equity Fund IX, L.P. Mid Buyout 2017 $2,750.00 $2,750.00 Craton Equity Partners Craton Equity Investors II, L.P.
    [Show full text]
  • Preqin Industry News Download Data
    View the full edition of Spotlight at: https://www.preqin.com/docs/newsletters/pe/Preqin-Private-Equity-Spotlight-July-2014.pdf News Preqin Industry News Download Data Preqin Industry News Joel Coulson and Chloe Wong take a look at the European venture capital market, including Europe-focused venture capital funds that have recently launched or held a final close, as well as prominent venture capital deals in the region. Several notable European venture capital financings were announced recently: How has venture capital deal activity changed in recent years? In June 2014, Kobalt Music Group Ltd, a global music publisher and music services company that offers administrative and Chart of the Month: Number and Value of Venture creative expertise, raised $115mn funding, of a $140mn round, Capital Deals in Europe, Q1 2007 - Q2 2014 from returning investor Balderton Capital and other unspecifi ed investors. MSD Capital committed $25mn of the $140mn funding 500 3.0 round in February 2014, via primary investment and also the 450 (€bn) Aggregate Deal Value acquisition of a stake from SPARK Ventures, which sold its last 2.5 400 remaining shares in the company. 350 2.0 Elasticsearch, a Dutch open source search engine, added $70mn 300 funding in June 2014 to its $34mn prior funding having raised series 250 1.5 A and series B rounds from Benchmark Capital, Data Collective, 200 No. of Deals 1.0 Index Ventures and SV Angel in November 2012 and February 150 2013. The recent series C round was led by new investor New 100 Enterprise Associates with participation from returning investors 0.5 50 Benchmark Capital and Index Ventures.
    [Show full text]
  • Annual Report 2014 Contents Castle Private Equity AG 2014
    Annual Report 2014 Contents Castle Private Equity AG 2014 Contents 03 Castle Private Equity in 2014 04 Chairman’s statement 06 Investment manager’s report 14 Report of the statutory auditor on the consolidated financial statements 16 Consolidated financial statements 64 Report of the statutory auditor on the company financial statements 66 Company financial statements 74 Report of the statutory auditor on the remuneration report 76 Remuneration report 79 Corporate governance 90 Investors’ information Further information Periodic updates of elements of this annual report and supplementary information can be retrieved from the company’s website www.castlepe.com Publication date This report was released for publication on 4 March 2015. The subsequent event notes in the financial statements have been updated to 18 February 2015. Amounts in this report are stated in USD thousands (TUSD) unless otherwise stated. This document is for information only and is not an offer to sell or an invitation to invest. In particular, it does not constitute an offer or solicitation in any jurisdiction where it is unlawful or where the person making the offer or solicitation is not qualified to do so or the recipient may not lawfully receive any such offer or solicitation. It is the responsibility of any person in possession of this document to inform themselves of, and to observe, all applicable laws and regulations of relevant jurisdictions. All statements contained herein that are not historical facts including, but not limited to, statements regarding anticipated activity are forward looking in nature and involve a number of risks and uncertainties. Actual results may differ materially.
    [Show full text]
  • Program Analysis Based Approaches to Ensure Security and Safety of Emerging Software Platforms
    Program Analysis Based Approaches to Ensure Security and Safety of Emerging Software Platforms by Yunhan Jia A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Computer Science and Engineering) in The University of Michigan 2018 Doctoral Committee: Professor Z. Morley Mao, Chair Professor Atul Prakash Assistant Professor Zhiyun Qian, University of California Riverside Assistant Professor Florian Schaub Yunhan Jia [email protected] ORCID iD: 0000-0003-2809-5534 c Yunhan Jia 2018 All Rights Reserved To my parents, my grandparents and Xiyu ii ACKNOWLEDGEMENTS Five years have passed since I moved into the Northwood cabin in Ann Arbor to chase my dream of obtaining a Ph.D. degree. Now, looking back from the end of this road, there are so many people I would like to thank, who are an indispensable part of this wonderful journey full of passion, love, learning, and growth. Foremost, I would like to gratefully thank my advisor, Professor Zhuoqing Morley Mao for believing and investing in me. Her constant support was a definite factor in bringing this dissertation to its completion. Whenever I got lost or stucked in my research, she would always keep a clear big picture of things in mind and point me to the right direction. With her guidance and support over these years, I have grown from a rookie to a researcher that can independently conduct research. Besides my advisor, I would like to thank my thesis committee, Professor Atul Prakash, Professor Zhiyun Qian, and Professor Florian Schaub for their insightful suggestions, com- ments, and support.
    [Show full text]
  • Futures Market Opening Up
    CHINA DAILY HONG KONG EDITION Friday, July 6, 2018 Markets | BUSINESS 21 Futures market opening up UK’s Winton Group to develop onshore ry environment improves, the firm’s Chinese business investment products within 2 months will have the biggest upside globally. By CAI XIAO in dominance, while some We are going to Man Group launched its and ZHOU LANXU other markets, such as egg, first onshore fund called AHL are unique. launch a futures China CTA in December, London-based hedge fund Yang said Winton Group focusing initially on listed manager Winton Group Ltd has a strong, long-term com- fund product in futures, including agricultur- said it will launch a futures mitment to the Chinese mar- al commodities, industrial fund in China within two ket and will seize the China within one commodities, bonds, metals, months, reflecting its opti- opportunity brought about or two months ...” and energy and stock indices. mism about the nation’s asset by the further opening-up of The company registered its management market. the country’s financial sec- Yang Min, CEO of Winton China second onshore fund in May, Winton has just successful- tor. focusing on the Chinese ly registered as a private secu- The onshore fund will use a A-share market. rities investment fund diversified trading strategy bear our international and Deng Haiqing, visiting manager with the Asset Man- based on data collection and local experience for the bene- finance professor at Renmin agement Association of Chi- analysis. The target clients fit of our Chinese clients.” University of China, said with Visitors check out services of Liepin, an online job search company listed in Hong Kong, at the compa- na, which will enable it to include Chinese banks, third- A Deloitte report showed more foreign asset manage- ny’s booth during a high-tech exhibition in Beijing.
    [Show full text]
  • The Handbook of Financing Growth
    ffirs.qxd 2/15/05 12:30 PM Page iii The Handbook of Financing Growth Strategies and Capital Structure KENNETH H. MARKS LARRY E. ROBBINS GONZALO FERNÁNDEZ JOHN P. FUNKHOUSER John Wiley & Sons, Inc. ffirs.qxd 2/15/05 12:30 PM Page b ffirs.qxd 2/15/05 12:30 PM Page a Additional Praise For The Handbook of Financing Growth “The authors have compiled a practical guide addressing capital formation of emerging growth and middle-market companies. This handbook is a valuable resource for bankers, accountants, lawyers, and other advisers serving entrepreneurs.” Alfred R. Berkeley Former President, Nasdaq Stock Market “Not sleeping nights worrying about where the capital needed to finance your ambitious growth opportunities is going to come from? Well, here is your answer. This is an outstanding guide to the essential planning, analy- sis, and execution to get the job done successfully. Marks et al. have cre- ated a valuable addition to the literature by laying out the process and providing practical real-world examples. This book is destined to find its way onto the shelves of many businesspeople and should be a valuable ad- dition for students and faculty within the curricula of MBA programs. Read it! It just might save your company’s life.” Dr. William K. Harper President, Arthur D. Little School of Management (Retired) Director, Harper Brush Works and TxF Products “Full of good, realistic, practical advice on the art of raising money and on the unusual people who inhabit the American financial landscape. It is also full of information, gives appropriate warnings, and arises from a strong ethical sense.
    [Show full text]
  • A Report Commissioned by Microsoft in Collaboration with BCS and Intellect
    A report commissioned by Microsoft in collaboration with BCS and Intellect December 2008 Developing the Future 2008 Contents Section 1 Skills: The Foundation of the UK Software Economy ....................... 5 Part 1.01 Graduates Entering the Software Industry ................................... 6 Part 1.02 cpSTEM Graduates employment trends ..................................... 15 Part 1.03 Who does the Software/IT sector want?.................................... 22 Part 1.04 Conclusions and Recommendations .......................................... 24 Section 2 Innovation, Entrepreneurship and Investment: Feeding the UK Software Economy ........................................................................................ 30 Part 2.01 Innovation in the UK ................................................................ 31 Part 2.02 Venture Capital Activity in the UK ............................................. 41 Part 2.03 Regional Distribution of UK VC-Backed Software Companies ....... 51 Part 2.04 University Research ................................................................. 59 Section 3 Building on the Strengths: The Growth of the UK Software Economy 70 Part 3.01 The UK Software Company Landscape ...................................... 71 Part 3.02 Outsourcing and Offshoring ...................................................... 74 Part 3.03 Digital Media ........................................................................... 88 Part 3.04 Video Games ..........................................................................
    [Show full text]